Non‐invasive cell‐free DNA‐based approach for the diagnosis of clinical miscarriage: A retrospective study
BJOG: An International Journal of Obstetrics & Gynaecology · 2024
DOI: 10.1111/1471-0528.17629 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Nuria Balaguer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Prenatal Diagnosis Department, Igenomix Spain Lab S.L.U., Paterna, Spain. Hauptthemen laut MEDLINE: Abortion, Spontaneous, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Igenomix.
Abstract (Originalsprache)
Objective
To evaluate cell‐free DNA (cfDNA) testing as a non‐invasive approach to detecting aneuploidies in clinical miscarriages.
Design
A retrospective cohort study of women with pregnancy loss.
Setting
Hospitals and genetic analysis laboratories. Population or sample Pregnancy losses in the period 2021–2022.
Methods
Results derived from non‐invasive cfDNA testing (Veriseq NIPT Solution V2) of maternal blood and invasive analysis of products of conception (POC) (Ion ReproSeq) compared in 120 women who suffered a miscarriage. Main outcome measures Concordance rate results, cfDNA testing performance, non‐informative rate (NIR) and fetal fraction (FF).
Results
We found no significant differences in the NIR between invasive (iPOC) and non‐invasive (niPOC) analysis of POC (10.0% [12/120] versus 16.7% [20/120]). Of 120 samples, 90 provided an informative result in iPOC and niPOC groups (75%). cfDNA analysis correctly identified 74/87 (85.1%) samples (excluding triploidies). Sensitivity and specificity were 79.4% and 100%, respectively; all discordant cases were female. A binomial logistic model suggested fetal sex as the only variable influencing the concordance rate ( P = 0.035). A Y‐chromosome‐based FF estimate allowed the optimal reclassification of cfDNA of non‐informative male fetuses and a more accurate evaluation of cfDNA testing performance. The difference between the two FF estimates (native algorithm and Y‐chromosome‐based) suggests that female non‐concordant cases may represent non‐informative cases.
Conclusions
Cell‐free DNA‐based testing provides a non‐invasive approach to determining the genetic cause of clinical miscarriage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Prenatal Diagnosis Department, Igenomix Spain Lab S.L.U., Paterna, Spain.
- Preimplantation Genetic Testing for Aneuploidies (PGT-A) Department, Igenomix Spain Lab S.L.U., Paterna, Spain.
- Medical Department, Igenomix R&D, Paterna, Spain.
- Igenomix Academy, Medel Bidco S.L.U., Paterna, Spain.
- Research and Development Department, Igenomix Spain Lab S.L.U., Paterna, Spain.
ORCID-Profile: Miguel Milán
Förderung
- Igenomix
Zitieren
APA
Balaguer, N., Rodrigo, L., Mateu-Brull, E., Campos-Galindo, I., Castellón, J. A., Al-Asmar, N., Rubio, C., & Milán, M. (2024). Non‐invasive cell‐free DNA‐based approach for the diagnosis of clinical miscarriage: A retrospective study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17629
Vancouver
Balaguer N, Rodrigo L, Mateu-Brull E, Campos-Galindo I, Castellón JA, Al-Asmar N, et al. Non‐invasive cell‐free DNA‐based approach for the diagnosis of clinical miscarriage: A retrospective study. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17629
BibTeX
@article{Balaguer2024,
author = {Balaguer, Nuria and Rodrigo, Lorena and Mateu-Brull, Emilia and Campos-Galindo, Inmaculada and Castellón, José Antonio and Al-Asmar, Nasser and Rubio, Carmen and Milán, Miguel},
title = {Non‐invasive cell‐free DNA‐based approach for the diagnosis of clinical miscarriage: A retrospective study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
doi = {10.1111/1471-0528.17629}
}
EUVIMED